Search Results - M. Tees
- Showing 1 - 2 results of 2
-
1
P682: NEMTABRUTINIB (MK-1026), A NON-COVALENT INHIBITOR OF WILD-TYPE AND C481S MUTATED BRUTON TYROSINE KINASE FOR B-CELL MALIGNANCIES: EFFICACY AND SAFETY OF THE PHASE 2 DOSE-EXPAN... by J. Woyach, I. W. Flinn, F. T. Awan, H. Eradat, D. Brander, M. Tees, S. A. Parikh, T. Phillips, W. Wang, N. M. Reddy, M. Z. Farooqui, J. C. Byrd, D. M. Stephens
Published in HemaSphere (2022-06-01)Get full text
Article -
2
P649: A FIRST-IN-HUMAN PHASE 1 TRIAL OF NX-2127, A FIRST-IN-CLASS ORAL BTK DEGRADER WITH IMID-LIKE ACTIVITY, IN PATIENTS WITH RELAPSED AND REFRACTORY B-CELL MALIGNANCIES by A. Mato, A. Danilov, M. R. Patel, M. Tees, I. Flinn, W. Ai, K. Patel, M. Wang, S. M. O’Brien, S. Nandakumar, M. Tan, E. Meredith, M. Gessner, S. Y. Kim, A. Wiestner, W. G. Wierda
Published in HemaSphere (2022-06-01)Get full text
Article
